Back
Array Technologies Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
32
ARRY
Array Technologies
Last Price:
6.45
Seasonality Move:
-7.01%
Sell
32
BMRN
Biomarin Pharmaceutical
Last Price:
68.71
Seasonality Move:
11.99%
Sell
32
Array Technologies (ARRY)
is a Sell
Is Array Technologies a Buy, Sell or Hold?
- The current Array Technologies [ARRY] share price is $6.48. The Score for ARRY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ARRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $68.96. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARRY Stock Price Chart
What is Array Technologies's stock price today?
-
The Array Technologies share price today is $6.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARRY is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $68.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
ARRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 45.92 | Sell |
| Chaikin Money Flow: | -1078856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.2 - 6.84) | Sell |
| Bollinger Bands (100): | (6.79 - 12.13) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.13 | Sell |
| Relative Strength Index (14 RSI): | 29.24 | Sell |
| Chaikin Money Flow: | 270547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.81 - 83.61) | Sell |
| Bollinger Bands (100): | (75.16 - 88.58) | Sell |
ARRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.53 | Sell |
| 20-day SMA: | 6.54 | Sell |
| 50-day SMA: | 7.15 | Sell |
| 200-day SMA: | 11.6 | Sell |
| 8-day EMA: | 6.48 | Sell |
| 20-day EMA: | 6.58 | Sell |
| 50-day EMA: | 7.41 | Sell |
| 200-day EMA: | 11.3 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.69 | Sell |
| 20-day SMA: | 72.88 | Sell |
| 50-day SMA: | 82.11 | Sell |
| 200-day SMA: | 85.37 | Sell |
| 8-day EMA: | 69.73 | Sell |
| 20-day EMA: | 73.23 | Sell |
| 50-day EMA: | 78.72 | Sell |
| 200-day EMA: | 84.16 | Sell |
Array Technologies Earnings Growth & ARRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.31 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Array Technologies Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||